Welcome to
TARGEDYS
Our mission is to control metabolic disease by modulating the appetite through an intervention
on the microbiome.
My dear homeland, I know you are suffering and in pain I know it is hard for you because strangers burn you and seek your destruction But your real children who are looking to build you are very hard but with full courage trying to pull you out of these bad days
Probiotic Strain H. alvei HA4597® Improves Weight Loss in Overweight Subjects: Multicenter Randomized, Double-Blind Placebo-Controlled Study www.mdpi.com/1133608 via @MDPIOpenAccess #microbiome #hafnia #probiotic #precibiomic #weight #glycemia #HA4597They talk about us ! @PourlaScience talks about the role of the #ClpB protein in regulating appetite via the #gut-#brain axis.
WHO ARE WE?
OUR UNIQUE APPROACH
Is to use the concept of molecular mimicry to physiologically bind well-described pharmacological targets with bacterial metabolites and derived small molecules
TargEDys® translates its unique understanding of the gut-brain axis to develop and manufacture nutritional and therapeutic solutions to control metabolic diseases. The company aims to be at the forefront of safe and effective weight management to improve the health and life quality of many over and underweight people.
The TargEDys research team at the INSERM lab of Rouen University has identified a novel mechanism of appetite regulation involving bacterial, hormonal mimetic, proteins that are found naturally in the gut microbiome. This mechanism acts as the basis of TargEDys' two technologies: ProbioSatys™ and ProbioNutrys™, which respectively moderate the appetite of overweight people and restore the appetite of elderly, cachexic or anorexic people.
OUR FOCUS
Overweight
1.4B
people (>20yrs) are overweight
(WHO, 2009)
5th
biggest risk factor for
death is obesity
(WHO, 2014)
50%
of the population in France are overweight
(INVS, 2016)
70%
of the US population are affected by obesity and overweight
(OECD, 2017)
13%
of the worldwide adult population are obese
(The Lancet, 2016)
Underweight
70M
people worldwide suffering from eating disorders
(Renfrew, 2003)
3ème
most common chronic illness for adolescents is anorexia
(Yeo&Hughes, 2011)
50-80%
of cancer patients
are affected
by cachexia
(Anker, 2014)
20%
of cancer deaths
are caused
by cachexia
(Takabe, 2015)
30-60%
of elderly
people are
undernourished
(Bozzetti, 2010)
OUR TIMELINE
